NCT01261247 2022-05-24Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaMayo ClinicPhase 2 Completed41 enrolled 8 charts
NCT00918333 2020-03-10Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin LymphomaMayo ClinicPhase 1/2 Completed124 enrolled 10 charts
NCT01321346 2015-11-24A Study Of Panobinostat In Children With Refractory Hematologic MalignanciesTherapeutic Advances in Childhood Leukemia ConsortiumPhase 1 Completed30 enrolled
NCT00962507 2013-02-15Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaCity of Hope Medical CenterPhase 1 Completed11 enrolled